Alexey Yu. Fedorov
Papers
1
Total Citations
72
H-Index
1
About
Dr. Alexey Yu. Fedorov is a leading figure in medicinal chemistry and drug discovery, whose work bridges the critical gap between hit identification and lead optimization. His primary research focuses on developing innovative synthetic methodologies and integrated strategies to accelerate the hit-to-lead (H2L) process, a major bottleneck in pharmaceutical development. Fedorov’s most notable contribution is the "Diversity-Oriented-Target-Focused-Synthesis" (DOTFS) approach, a time- and cost-efficient strategy for fragment growing that automates lead optimization. This landmark work, published in 2018 and garnering 72 citations, has been widely recognized for its potential to streamline drug discovery pipelines. By combining diversity-oriented synthesis with target-focused design, Fedorov’s methodology enables rapid exploration of chemical space while maintaining biological relevance, offering a practical solution to one of the field’s most persistent challenges. His research continues to influence both academic and industrial settings, providing a robust framework for converting screening hits into viable drug candidates. Fedorov’s work exemplifies how strategic synthetic design can overcome traditional hurdles in medicinal chemistry, making him a key innovator in the quest for more efficient drug development.
Research Focus
Key Achievements
Top Papers
- 1